A carregar...

Novel iridium (III)-derived organometallic compound for the inhibition of human platelet activation

Since cisplatin achieved clinical success, transition metal platinum (Pt) drugs have been effectively used for the treatment of cancer. Iridium (Ir) compounds are considered to be potential alternatives to Pt compounds, as they possess promising anticancer effects with minor side effects. Platelet a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Mol Med
Main Authors: Shyu, Kou-Gi, Velusamy, Marappan, Hsia, Chih-Wei, Yang, Chih-Hao, Hsia, Chih-Hsuan, Chou, Duen-suey, Jayakumar, Thanasekaran, Sheu, Joen-Rong, Li, Jiun-Yi
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5846649/
https://ncbi.nlm.nih.gov/pubmed/29436605
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijmm.2018.3472
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!